Clinical trial Recruiting at 1 site Observational

Evaluating cerebral blood flow using a new method from angiography

Official title: The Association Between a New Parameter Derived From DSA and Outcomes in Cerebral Ischemia

Run by Xi'an No.3 Hospital · NCT03607565 · Data updated 2026-11-12

This study is trying to see if a new way of looking at brain blood flow from angiography can help predict recovery in patients who have had a stroke caused by blocked blood vessels.

Quick facts

Study typeObservational
SexAll
Enrollment30000 (estimated)
SponsorXi'an No.3 Hospital
Government
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedJuly 15, 2018
Main results expectedJuly 15, 2028
Study endsJuly 15, 2038
Registry record updatedSeptember 1, 2023
Trial IDNCT03607565 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with cerebral ischemia who have undergone Digital Subtraction Angiography.

Probably not a fit

Patients with cerebral hemorrhage will not benefit from this study as they do not meet the inclusion criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess a new parameter derived from Digital Subtraction Angiography (DSA) to evaluate cerebral perfusion in patients with cerebral ischemia. By analyzing DSA images and correlating them with patient outcomes measured by the modified Rankin Scale, the study seeks to establish a relationship between this new parameter and the prognosis of acute stroke with large vessel occlusion. The research focuses on retrospective data analysis of patients who have undergone DSA to better understand cerebral blood flow dynamics.

Why it matters

Potential benefit: If successful, this study could improve the prediction of outcomes for patients suffering from acute stroke due to large vessel occlusion.

How similar studies have gone: While the approach of using DSA-derived parameters is established, the specific application of this new parameter in predicting outcomes in cerebral ischemia is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Cerebral ischemia
2. patients undergone DSA

Exclusion Criteria:

1.cerebral hemorrhage

Where it's running

  • Xi'an No.3 Hospital
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.